
If you take a blood pressure pill every morning without thinking about it, this one is worth two minutes with your pill bottle.
Macleods Pharma USA, a New Jersey-based drugmaker, has recalled 3,744 bottles of a prescription blood pressure medication after the FDA said the pills failed quality testing. The company started the recall on Oct. 7, and the FDA classified it on Oct. 26.
Most people taking these pills have no idea. The FDA didn't put out a news release.
What Was Recalled
The product is a combination tablet: olmesartan medoxomil, amlodipine and hydrochlorothiazide, in a 40 mg/10 mg/12.5 mg strength. Two lots are affected, and both were distributed nationwide.
The first is lot 12251163A, which covers 3,528 bottles of 30 tablets each. The second is lot 12251163B, which covers 216 bottles of 90 tablets each. Both lots expire May 31, 2027, so the pills could still be in medicine cabinets right now.
The Problem With the Pills

The FDA lists the reason as "failed dissolution specifications." In plain English, the pills didn't break down the way they're supposed to when tested in liquid.
That matters because a tablet has to dissolve before your body can absorb the drug inside it. In this case, the olmesartan component fell short. The manufacturer says the tablets could reduce or delay absorption, which could cause a temporary dip in blood pressure control.
A pill that doesn't dissolve properly can't reliably deliver the dose printed on the label.
What "Class II" Means
The FDA classified the recall as Class II. That means taking the product may cause temporary or medically reversible health problems, and the chance of serious harm is considered remote.
The FDA didn't issue a news release. According to its enforcement report, letters went out to businesses and to people who may have the medication. That's why a recall affecting thousands of bottles has barely made noise.
What to Do If You Take This Medication
First, check your bottle. Look for the lot number and compare it against 12251163A and 12251163B. Your pharmacy label or the bottle itself should show it. If you can't find it, call the pharmacy and ask whether your fill came from either lot.
Second, don't stop taking your blood pressure medication on your own. The standard guidance on these recalls is to talk to your pharmacist or doctor first, because going without blood pressure medication can carry its own risks. If your pills are from an affected lot, they can tell you how to replace them.
Third, report anything unusual. If your blood pressure readings have been higher than normal lately, mention it to your doctor and tell them about the recall.
It's Not the Only One

A separate recall hit blood pressure medication in the same weeks. Ascend Laboratories recalled 11,424 bottles of a combined amlodipine and olmesartan medoxomil tablet, lot 25120696, which expires Dec. 31, 2026. The FDA also classified that one as Class II, citing failed specifications.
Two recalls of similar drugs in a matter of weeks doesn't mean your medication is unsafe. It does mean this is a good week to read the label on your bottle.














